Recently, medical device company Vmei Medical announced that it has completed a Pre-C round of strategic financing worth tens of millions of RMB. The round was exclusively invested by SBI Group, with Kaitou Capital serving as the long-term exclusive financial advisor.
According to public information, Vmei Medical was established on July 23, 2021, and is a high-tech enterprise focused on the research and development of medical devices. One of the company’s flagship medical aesthetics products is the YOUMAGIC Shuliti High-Energy Monopolar RF Skin Treatment Device, which promotes an anti-aging experience that is “higher energy, more comfortable, and more effective.” It is also the first radiofrequency device in China to obtain both a Class III medical device certification from the NMPA and certification from the FDA.
It is reported that the funds from this round of financing will mainly be used in four key areas. First, to continue upgrading the core technology of the Shuliti device and further strengthen its technological barriers. Second, to improve the clinical data system and advance multi-center validation to reinforce the product’s evidence-based foundation. Third, to build domestic and international registration and compliance capabilities, paving the way for the product’s global expansion. Fourth, to strengthen international team-building and organizational capabilities in order to support the company’s comprehensive expansion into global markets.
It is worth noting that since its establishment, Vmei Medical has developed rapidly and has completed a total of 12 financing rounds. Among its investors are several well-known Chinese beauty companies and prominent investment institutions, including Proya, Botanee, and Ziniu Fund. Notably, Botanee invested in the company twice, in both 2023 and 2024
